What does specialty surgery — operating income (loss) mean?

This metric measures the profitability of the Specialty Surgery segment by subtracting total operating costs from segment revenues. It is the primary indicator of the segment's operational efficiency and its ability to contribute to the company's overall bottom-line performance.

Integra LifeSciences IART Specialty Surgery — Operating Income (Loss)

Other segment segments

Tissue Reconstruction

$20.27M—

Similar metrics at other companies

AMRXSpecialty — Operating Income (Loss)

$50.06M+234%

APGSpecialty Services — Operating Income (Loss)

$39M+34.5%

PRGOSpecialty Care — Operating income (loss)

$55.3M+31.4%

BCPCSpecialty Products — Operating Income (Loss)

$11.94M+24.5%

SCLSpecialty Products — Operating Income

$4.72M-14.4%

BLCOSurgical — Operating Income (Loss)

$9M+229%

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B+53.4%

Enterprise value$3.12B+21.1%

P/S0.8×+0.3×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's specialty surgery — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's specialty surgery — operating income (loss)?: Integra LifeSciences (IART) reported specialty surgery — operating income (loss) of $83.13M in Q1 2026.
What does specialty surgery — operating income (loss) mean?: This metric measures the profitability of the Specialty Surgery segment by subtracting total operating costs from segment revenues. It is the primary indicator of the segment's operational efficiency and its ability to contribute to the company's overall bottom-line performance.